FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2613380263> ?p ?o ?g. }

• W2613380263 endingPage "276" @default.
• W2613380263 startingPage "263" @default.
• W2613380263 abstract "Background: Psoriasis, a chronic inflammatory disease associated with an accelerated risk of myocardial infarction, provides an ideal human model to study inflammatory atherogenesis in vivo. We hypothesized that the increased cardiovascular risk observed in psoriasis would be partially attributable to an elevated subclinical coronary artery disease burden composed of noncalcified plaques with high-risk features. However, inadequate efforts have been made to directly measure coronary artery disease in this vulnerable population. As such, we sought to compare total coronary plaque burden and noncalcified coronary plaque burden (NCB) and high-risk plaque (HRP) prevalence between patients with psoriasis (n=105), patients with hyperlipidemia eligible for statin therapy under National Cholesterol Education Program-Adult Treatment Panel III guidelines (n=100) who were ≈10 years older, and healthy volunteers without psoriasis (n=25). Methods: Patients underwent coronary computed-tomography angiography for total coronary plaque burden and NCB quantification and HRP identification, defined as low attenuation (<30 hounsfield units), positive remodeling (>1.10), and spotty calcification. A consecutive sample of the first 50 patients with psoriasis was scanned again 1 year after therapy. Results: Despite being younger and at lower traditional risk than patients with hyperlipidemia, patients with psoriasis had increased NCB (mean±SD: 1.18±0.33 versus 1.11±0.32, P =0.02) and similar HRP prevalence ( P =0.58). Furthermore, compared to healthy volunteers, patients with psoriasis had increased total coronary plaque burden (1.22±0.31 versus 1.04±0.22, P =0.001), NCB (1.18±0.33 versus 1.03±0.21, P =0.004), and HRP prevalence beyond traditional risk (odds ratio, 6.0; 95% confidence interval, 1.1–31.7; P =0.03). Last, among patients with psoriasis followed for 1 year, improvement in psoriasis severity was associated with improvement in total coronary plaque burden (β=0.45, 0.23–0.67; P <0.001) and NCB (β=0.53, 0.32–0.74; P <0.001) beyond traditional risk factors. Conclusions: Patients with psoriasis had greater NCB and increased HRP prevalence than healthy volunteers. In addition, patients with psoriasis had elevated NCB and equivalent HRP prevalence as older patients with hyperlipidemia. Last, modulation of target organ inflammation (eg, skin) was associated with an improvement in NCB at 1 year, suggesting that control of remote sites of inflammation may translate into reduced coronary artery disease risk." @default.
• W2613380263 created "2017-05-19" @default.
• W2613380263 creator A5004459215 @default.
• W2613380263 creator A5005047752 @default.
• W2613380263 creator A5020348286 @default.
• W2613380263 creator A5025791584 @default.
• W2613380263 creator A5029448532 @default.
• W2613380263 creator A5037356234 @default.
• W2613380263 creator A5044522751 @default.
• W2613380263 creator A5046064986 @default.
• W2613380263 creator A5050340607 @default.
• W2613380263 creator A5053807316 @default.
• W2613380263 creator A5057317213 @default.
• W2613380263 creator A5066516536 @default.
• W2613380263 creator A5069063369 @default.
• W2613380263 creator A5077687421 @default.
• W2613380263 creator A5080726626 @default.
• W2613380263 creator A5086010156 @default.
• W2613380263 creator A5086804964 @default.
• W2613380263 date "2017-07-18" @default.
• W2613380263 modified "2023-10-14" @default.
• W2613380263 title "Coronary Plaque Characterization in Psoriasis Reveals High-Risk Features That Improve After Treatment in a Prospective Observational Study" @default.
• W2613380263 cites W109837811 @default.
• W2613380263 cites W1552829599 @default.
• W2613380263 cites W193971504 @default.
• W2613380263 cites W1947718272 @default.
• W2613380263 cites W1975647660 @default.
• W2613380263 cites W1986765542 @default.
• W2613380263 cites W2018637416 @default.
• W2613380263 cites W2019071303 @default.
• W2613380263 cites W2022665587 @default.
• W2613380263 cites W2047354818 @default.
• W2613380263 cites W2062864086 @default.
• W2613380263 cites W2067687558 @default.
• W2613380263 cites W2071936488 @default.
• W2613380263 cites W2082622860 @default.
• W2613380263 cites W2086798320 @default.
• W2613380263 cites W2095652983 @default.
• W2613380263 cites W2097499476 @default.
• W2613380263 cites W2106831032 @default.
• W2613380263 cites W2116083791 @default.
• W2613380263 cites W2142119629 @default.
• W2613380263 cites W2142687288 @default.
• W2613380263 cites W2150795824 @default.
• W2613380263 cites W2152465587 @default.
• W2613380263 cites W2156919621 @default.
• W2613380263 cites W2158137410 @default.
• W2613380263 cites W2168536722 @default.
• W2613380263 cites W2169773326 @default.
• W2613380263 cites W2264045234 @default.
• W2613380263 cites W2469096048 @default.
• W2613380263 cites W2508251329 @default.
• W2613380263 cites W2519634482 @default.
• W2613380263 cites W2556512023 @default.
• W2613380263 cites W2561759163 @default.
• W2613380263 cites W2569653437 @default.
• W2613380263 cites W2734835321 @default.
• W2613380263 cites W3001764054 @default.
• W2613380263 cites W4230870013 @default.
• W2613380263 cites W594638714 @default.
• W2613380263 cites W988932408 @default.
• W2613380263 doi "https://doi.org/10.1161/circulationaha.116.026859" @default.
• W2613380263 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5534138" @default.
• W2613380263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28483812" @default.
• W2613380263 hasPublicationYear "2017" @default.
• W2613380263 type Work @default.
• W2613380263 sameAs 2613380263 @default.
• W2613380263 citedByCount "108" @default.
• W2613380263 countsByYear W26133802632017 @default.
• W2613380263 countsByYear W26133802632018 @default.
• W2613380263 countsByYear W26133802632019 @default.
• W2613380263 countsByYear W26133802632020 @default.
• W2613380263 countsByYear W26133802632021 @default.
• W2613380263 countsByYear W26133802632022 @default.
• W2613380263 countsByYear W26133802632023 @default.
• W2613380263 crossrefType "journal-article" @default.
• W2613380263 hasAuthorship W2613380263A5004459215 @default.
• W2613380263 hasAuthorship W2613380263A5005047752 @default.
• W2613380263 hasAuthorship W2613380263A5020348286 @default.
• W2613380263 hasAuthorship W2613380263A5025791584 @default.
• W2613380263 hasAuthorship W2613380263A5029448532 @default.
• W2613380263 hasAuthorship W2613380263A5037356234 @default.
• W2613380263 hasAuthorship W2613380263A5044522751 @default.
• W2613380263 hasAuthorship W2613380263A5046064986 @default.
• W2613380263 hasAuthorship W2613380263A5050340607 @default.
• W2613380263 hasAuthorship W2613380263A5053807316 @default.
• W2613380263 hasAuthorship W2613380263A5057317213 @default.
• W2613380263 hasAuthorship W2613380263A5066516536 @default.
• W2613380263 hasAuthorship W2613380263A5069063369 @default.
• W2613380263 hasAuthorship W2613380263A5077687421 @default.
• W2613380263 hasAuthorship W2613380263A5080726626 @default.
• W2613380263 hasAuthorship W2613380263A5086010156 @default.
• W2613380263 hasAuthorship W2613380263A5086804964 @default.
• W2613380263 hasBestOaLocation W26133802631 @default.
• W2613380263 hasConcept C113280763 @default.
• W2613380263 hasConcept C126322002 @default.
• W2613380263 hasConcept C134018914 @default.
• W2613380263 hasConcept C16005928 @default.

• next